Seeing Is Believing
Currently out of the existing stock ratings of Howard Liang, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst Howard Liang works with a stock forecast success ratio of 100% fulfilled within 1099 days on average. Previously, Howard Liang worked at LEERINK.
Howard Liang’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 22-Apr-2015.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 10/2/2013. The price target of $128 was fulfilled within 393 days with a profit of $39.47 (44.58%) receiving and performance score of 1.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
300
$-11.29 (-3.63%)
230
3 days ago
16/19 (84.21%)
$-11.29 (-3.63%)
237
Hold
307
$-4.29 (-1.38%)
284
3 days ago
9/10 (90%)
$-4.29 (-1.38%)
87
Buy
328
$16.71 (5.37%)
329
3 days ago
6/9 (66.67%)
$16.71 (5.37%)
68
Buy
355
$43.71 (14.04%)
326
3 days ago
17/19 (89.47%)
$43.71 (14.04%)
439
Hold
310
$-1.29 (-0.41%)
291
3 days ago
11/12 (91.67%)
$-1.29 (-0.41%)
758
What Year was the first public recommendation made by Howard Liang?